menu
    • menu

    Company profile for Gyroscope Therapeutics

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Gyroscope Therapeutics is a clinical-stage retinal gene therapy company developing and delivering gene therapy beyond rare disease to treat a leading cause of blindness, dry age-related macular degeneration. Our lead investigational gene therapy, GT005, is a one-time therapy delivered under the retina. GT005 is designed to restore balance to an overactive complement system by increasing production of the Complement Factor I pr...
    Gyroscope Therapeutics is a clinical-stage retinal gene therapy company developing and delivering gene therapy beyond rare disease to treat a leading cause of blindness, dry age-related macular degeneration. Our lead investigational gene therapy, GT005, is a one-time therapy delivered under the retina. GT005 is designed to restore balance to an overactive complement system by increasing production of the Complement Factor I protein. GT005 is currently being evaluated in a Phase I/II clinical trial called FOCUS and a Phase II clinical trial called EXPLORE.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Gyroscope Therapeuticsunitedkingdom_new Flag
    Country
    Country
    United Kingdom
    Address
    Address
    11-21 Northdown Street Northdown House London, England N19BN, GB
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.gyroscopetx.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/gyroscope-therapeutics/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/gyroscopetx?lang=en

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Syncona announces sale of portfolio company to Novartis
    Syncona announces sale of portfolio company to Novartis

    18 Feb 2022

    // John Pinching PHARMATIMES

    https://www.pharmatimes.com/news/all_trades_syncona_announces_sale_of_portfolio_company_to_novartis_1387891

    John Pinching PHARMATIMES
    18 Feb 2022
    Share Share
    Novartis Bolsters Retinal Gene Therapy Position with $1.5 Billion Acquisition
    Novartis Bolsters Retinal Gene Therapy Position with $1.5 Billion Acquisition

    23 Dec 2021

    // Alex Keown BIOSPACE

    https://www.biospace.com/article/novartis-bolsters-retinal-gene-therapy-position-with-1-5-billion-buy-of-gyroscope-therapeutics/?s=71

    Alex Keown BIOSPACE
    23 Dec 2021
    Share Share
    Novartis buys UK's Gyroscope for $1.5B to get gene therapy for eye disease
    Novartis buys UK's Gyroscope for $1.5B to get gene therapy for eye disease

    21 Dec 2021

    // REUTERS

    https://www.reuters.com/article/gyroscope-therapeutics-m-a-novartis/novartis-buys-uks-gyroscope-for-1-5-billion-to-get-gene-therapy-for-eye-disease-idUSKBN2J10GC

    REUTERS
    21 Dec 2021
    Share Share
    Gyroscope spins the wheel again as it taps Sanofi for $60M
    Gyroscope spins the wheel again as it taps Sanofi for $60M

    09 Nov 2021

    // Phil Taylor PHARMAPHORUM

    https://pharmaphorum.com/news/sanofi-winds-40m-into-uk-gene-therapy-firm-gyroscope/

    Phil Taylor PHARMAPHORUM
    09 Nov 2021
    Share Share
    Sanofi invests $40m in UK gene therapy company Gyroscope Therapeutics
    Sanofi invests $40m in UK gene therapy company Gyroscope Therapeutics

    09 Nov 2021

    // Lucy Parsons PHARMATIMES

    https://www.pharmatimes.com/news/sanofi_invest_$40m_in_uk_gene_therapy_company_gyroscope_therapeutics_1383225

    Lucy Parsons PHARMATIMES
    09 Nov 2021
    Share Share
    AI upstart grabs $40M launch round; Sanofi backs gene therapy player; & more
    AI upstart grabs $40M launch round; Sanofi backs gene therapy player; & more

    08 Nov 2021

    // Paul Schloesser\nJohn Carroll ENDPTS

    https://endpts.com/ai-upstart-grabs-40m-launch-round-sanofi-backs-a-gene-therapy-player-axsome-hits-a-snag-at-the-fda/

    Paul Schloesser\nJohn Carroll ENDPTS
    08 Nov 2021
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search